Antidepressants: From Biogenic Amines to New Mechanisms of Action

Author Matthew Macaluso - Sheldon H. Preskorn

Publisher Springer

Format

eBook

2nd Edition 1st Edition

Quantity

Add New

Author

Matthew Macaluso - Sheldon H. Preskorn

Publisher

Springer

Volume

Copyright

2019

ISBN13

9783030109493

Release

Format

eBook

Grade Level

College Freshman - College Senior

DDC
TBD

Overview

This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs and outlines the most up to date evidence regarding the treatment of depression. Concise, yet comprehensive, in its review of clinical evidence, it appeals to both clinicians and researchers alike.
Front Cover.
Half Title Page.
Other Frontmatter.
Title Page.
Copyright Page.
Dedication.
Preface.
Contents.
1: Impact, Diagnosis, Phenomenology, and Biology.
2: Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?.
3: Clinical Implications of the STAR*D Trial.
4: Pharmacogenomics and Biomarkers of Depression.
5: Therapeutic Drug Monitoring of Antidepressants.
6: Selective Serotonin Reuptake Inhibitors.
7: Serotonin and Norepinephrine Reuptake Inhibitors.
8: Neurostimulation Therapies.
9: Current Role of Herbal and Natural Preparations.
10: Role of Inflammation in Depression and Treatment Implications.
11: NMDA Antagonists for Treatment-Resistant Depression.
12: Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development.
13: Other Antidepressants.
14: Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders.
15: Treatment of Depression in Women.
16: Management of Late-Life Depression.
17: The Use of Antidepressants in Bipolar Depression.
Read More Read Less

Antidepressants: From Biogenic Amines to New Mechanisms of Action

Product Details

Overview

Table of Contents